Getinge 2022 Annual Report

Getinge 2022 Annual Report ADJUSTED EBITA PER SEGMENT Introduction Strategy Corporate Governance Annual Report Sustainability Report Other information Contents Adjusted EBITA, 2022,SEK M Operating profit (EBIT) Acute Care Therapies 2,889 Life Science 600 Surgical Workflows Group functions and other Total 480 -343 3,626 Add back of: Amortization and write-down of acquired intangible assets 129 25 30 185 Other items affecting comparability 242 242 Acquisition and restructuring costs 142 24 39 22 228 Adjusted EBITA 3,402 650 549 -320 4,281 Group Other items affecting comparability, 2022, SEK M Provision related to surgical mesh implants Acute Care Therapies 231 Life Science Surgical Workflows functions and other Total 231 Other 11 11 Total 242 242 Acute Care Therapies Life Science Surgical Workflows Group functions and other Total 3,685 702 369 -386 4,371 Adjusted EBITA, 2021,SEK M Operating profit (EBIT) Add back of: Amortization and write-down of acquired intangible assets 229 25 19 273 Other items affecting comparability 529 -56 473 Acquisition and restructuring costs 1 2 58 35 95 Adjusted EBITA 4,444 729 390 -351 5,212 Group Acute Care Provision related to surgical mesh implants Other items affecting comparability, 2021, SEK M Capital gain on divestment of properties Therapies Life Science Surgical Workflows functions and other Total 601 601 -72 -72 Other Total 529 -56 -56 -56 473 186

View entire presentation